Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 129, Issue 1, 2005, Pages 45-52

  Shearer, Brandon M ^a   Flynn, Heather C ^a   Knudson, Ryan A ^a   Ketterling, Rhett P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute lymphoblastic leukaemia; E2A; Fluorescence in situ hybridization; PBX1; t(1; 19)(q23; p13.3)

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHILDHOOD LEUKEMIA; CHROMOSOME 19P; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; E2A GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE FUSION; GENE PROBE; HUMAN; HUMAN CELL; INTERPHASE; MINIMAL RESIDUAL DISEASE; MONITORING; PBX1 GENE; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, B-CELL, ACUTE; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 17144415888     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05415.x     Document Type: Article

References (32)

1. Borowitz, M.J., Hunger, S.P., Carroll, A.J., Shuster, J.J., Pullen, D.J., Steuber, C.P. & Cleary, M.L. (1993) Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukaemia for molecular analysis: a Pediatric Oncology Group study. Blood, 82, 1086-1091.
2. Brockman, S.R., Paternoster, S.F., Ketterling, R.P. & Dewald, G.W. (2003) New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia. Cancer Genetics and Cytogenetics, 145, 144-151.
3. Devaraj, P.E., Foroni, L., Janossy, G., Hoffbrand, A.V. & Seeker-Walker, L.M. (1995) Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia, 9, 821-825.
4. Dewald, G.W. (2002) Interphase FISH studies of chronic myeloid leukemia. In: Molecular Cytogenetics Protocols and Applications, Vol. 204 (ed. by Y.-S. Fan), pp. 311-342. Humana Press Inc., Totowa, NJ.
5. Dewald, G.W., Wyatt, W.A., Juneau, A.L., Carlson, R.O., Zinsmeister, A.R., Jalal, S.M., Spurbeck, J.L. & Silver, R.T. (1998) Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood, 91, 3357-3365.
6. Godon, C., Proffitt, J., Dastugue, N., Lafage-Pochitaloff, M., Mozziconacci, M.J., Talmant, P., Hackbarth, M., Bataille, R. & Avet-Loiseau, H. (2002) Large deletions 5′ to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia. Leukemia, 16, 1752-1754.
7. Hunger, S.P. (1996) Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood, 87, 1211-1224.
8. Hunger, S.P., Galili, N., Carroll, A.J., Crist, W.M., Link, M.P. & Cleary, M.L. (1991) The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood, 77, 687-693.
9. Izraeli, S., Janssen, J.W., Haas, O.A., Harbott, J., Brok-Simoni, F., Walther, J.U., Kovar, H., Henn, T., Ludwig, W.D., Reiter, A., Rechavi, G., Bartram, C.R., Gadner, H. & Lion, T. (1993) Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia, 7, 671-678.
10. Jaffe, E.S., Stein, H.N. & Vardiman, J.W. (eds) (2001). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC Press, Lyon, 111-114.
11. Kajsa Paulsson, A.H., Fioretos, T., Mitelman, F. & Johansson, B. (2005) Formation of der(19)t(1;19)(q23;p13) in acute lymphoblastic leukemia. Genes, Chromosomes and Cancer, 42, 144-148.
12. Kamps, M.P., Murre, C., Sun, X.H. & Baltimore, D. (1990) A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell, 60, 547-555.
13. Kolomietz, E., Al-Maghrabi, J., Brennan, S., Karaskova, J., Minkin, S., Lipton, J. & Squire, J.A. (2001) Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood, 97, 3581-3588.
14. Konig, M., Reichel, M., Marschalek, R., Haas, O.A. & Strehl, S. (2002) A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias. British Journal of Haematology, 116, 758-764.
15. Mellentin, J.D., Murre, C., Donion, T.A., McCaw, P.S., Smith, S.D., Carroll, A.J., McDonald, M.E., Baltimore, D. & Cleary, M.L. (1989) The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science, 246, 379-382.
16. Mellentin, J.D., Nourse, J., Hunger, S.P., Smith, S.D. & Cleary, M.L. (1990) Molecular analysis of the t(1;19) breakpoint cluster region in pre-B cell acute lymphoblastic leukemias. Genes, Chromosomes and Cancer, 2, 239-247.
17. Nourse, J., Mellentin, J.D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S.D. & Cleary, M.L. (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell, 60, 535-545.
18. Pardanani, A., Ketterling, R.P., Brockman, S.R., Flynn, H.C., Paternoster, S.F., Shearer, B.M., Reeder, T.L., Li, C.Y., Cross, N.C., Cools, J., Gilliland, D.G., Dewald, G.W. & Tefferi, A. (2003) CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood, 102, 3093-3096.
19. Pui, C.H., Raimondi, S.C., Hancock, M.L., Rivera, G.K., Ribeiro, R.C., Mahmoud, H.H., Sandlund, J.T., Crist, W.M. & Behm, F.G. (1994) Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23;p13) or its derivative. Journal of Clinical Oncology, 12, 2601-2606.
20. Pui, C.H., Relling, M.V. & Downing, J.R. (2004) Acute lymphoblastic leukaemia [see comment]. New England Journal of Medicine, 350, 1535-1548.
21. Raimondi, S.C., Privitera, E., Williams, D.L., Look, A.T., Behm, F., Rivera, G.K., Crist, W.M. & Pui, C.H. (1991) New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. Blood, 77, 2016-2022.
22. Seeker-Walker, L.M., Berger, R., Fenaux, P., Lai, J.L., Nelken, B., Garson, M., Michael, P.M., Hagemeijer, A., Harrison, C.J., Kaneko, Y. & Rubin, C.M. (1992) Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia, 6, 363-369.
23. Shikano, T., Kaneko, Y., Takazawa, M., Ueno, N., Ohkawa, M. & Fujimoto, T. (1986) Balanced and unbalanced 1;19 translocation-associated acute lymphoblastic leukemias. Cancer, 58, 2239-2243.
24. Sinclair, P.B., Nacheva, E.P., Leversha, M., Telford, N., Chang, J., Reid, A., Bench, A., Champion, K., Huntly, B. & Green, A.R. (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia [see comment]. Blood, 95, 738-743.
25. Smoley, S.A., Brockman, S.R., Paternoster, S.F., Meyer, R.G. & Dewald, G.W. (2004) A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia. Cancer Genetics and Cytogenetics, 148, 1-6.
26. Spurbeck, J.L., Carlson, R.O., Allen, J.E. & Dewald, G.W. (1988) Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genetics and Cytogenetics, 32, 59-66.
27. Troussard, X., Rimokh, R., Valensi, F., Leboeuf, D., Fenneteau, O., Guitard, A.M., Manel, A.M., Schillinger, F., Leglise, C., Brizard, A., Gardais, J., Lessard, M., Flandrin, G. & Macintyre, E. (1995) Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group. British Journal of Haematology, 89, 516-526.
28. Uckun, P.M., Sensel, M.G., Sather, H.N., Gaynon, P.S., Arthur, D.C., Lange, B.J., Steinherz, P.G., Kraft, P., Hutchinson, R., Nachman, J.B., Reaman, G.H. & Heerema, N.A. (1998) Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. Journal of Clinical Oncology, 16, 527-535.
29. Van Dijk, M.A., Voorhoeve, P.M. & Murre, C. (1993) Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 90, 6061-6065.
30. Wiemels, J.L., Cazzaniga, G., Daniotti, M., Eden, O.B., Addison, G.M., Masera, G., Saha, V., Biondi, A. & Greaves, M.F. (1999) Prenatal origin of acute lymphoblastic leukaemia in children [see comment]. Lancet, 354, 1499-1503.
31. Wiemels, J.L., Leonard, B.C., Wang, Y., Segal, M.R., Hunger, S.P., Smith, M.T., Grouse, V., Ma, X., Buffler, P.A. & Pine, S.R. (2002) Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 15101-15106.
32. Yuki, Y., Imoto, I., Imaizumi, M., Hibi, S., Kaneko, Y., Amagasa, T. & Inazawa, J. (2004) Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Science, 95, 503-507.